Originally published by our sister publication Pharmacy Practice News
By Gina Shaw
With shortages of IV fluids expected to persist for an undetermined length of time due to the severe damage caused by Hurricane Helene to Baxter International’s manufacturing facility in North Carolina, which produces some 60% of IV fluids used in U.S. hospitals and health systems, the FDA has issued a temporary guidance giving compounding pharmacies that are not licensed as 503A outsourcing facilities